Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Three Arch Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Three Arch Partners

Three Arch Partners

Operating

Three Arch Partners: A healthcare investment fund fostering innovation in medical devices and services since 1993.

Location
Portola Valley, CA, US
Founded
1993
Firm
Compare
Portfolio
Employees

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies.

These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.

Three Arch Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments49
Current Portfolio Count20
Total Portfolio Exits7

Top Investment Stages

Series B12 (29.3%)
Series C11 (26.8%)
Series A7 (17.1%)
Series D7 (17.1%)
Series Unknown4 (9.8%)

Stage Mix

Series B 29%Series C 27%Series A 17%Series D 17%Series Unknown 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Neuronetics logo

Neuronetics

Nevro logo

Nevro

Lite Strategy logo

Lite Strategy

VisionCare Ophthalmic Technologies logo

VisionCare Ophthalmic Technologies

Trireme Medical logo

Trireme Medical

Voyage Medical logo

Voyage Medical

SpinalMotion logo

SpinalMotion

WaveRx logo

WaveRx

Arete Therapeutics logo

Arete Therapeutics

APT Pharmaceuticals logo

APT Pharmaceuticals

Cameron Health logo

Cameron Health

NovaSys Health logo

NovaSys Health

Novasys Medical logo

Novasys Medical

Arbor Surgical Technologies logo

Arbor Surgical Technologies

Benvenue Medical logo

Benvenue Medical

Satiety logo

Satiety

Pegasus Biologics logo

Pegasus Biologics

SmoothShapes logo

SmoothShapes

AcuFocus logo

AcuFocus

NBI Development logo

NBI Development

Oculir logo

Oculir

Allux Medical logo

Allux Medical

Iscience Surgical logo

Iscience Surgical

NeuroBionics logo

NeuroBionics

Vitra Bioscience logo

Vitra Bioscience

Three Arch Partners - Similar Investment Firms

Arch Venture Partners logo

Arch Venture Partners

archventure.com

Tower Three Partners logo

Tower Three Partners

Three Fields Capital logo

Three Fields Capital

3P Equity Partners logo

3P Equity Partners

3pequity.com

TriStar Health Partners logo

TriStar Health Partners

Arch Development Partners logo

Arch Development Partners

archdp.com

Emergent Medical Partners logo

Emergent Medical Partners

emvllp.com

Triplepoint Capital logo

Triplepoint Capital

Archimedes Health Investors logo

Archimedes Health Investors

Great Point Partners logo

Great Point Partners

gppfunds.com

Alliance Healthcare Partners logo

Alliance Healthcare Partners

Arcus Ventures logo

Arcus Ventures

Tru Arrow Partners logo

Tru Arrow Partners

truarrow.com

Thirdbase Capital logo

Thirdbase Capital

thirdbasecap.com

Arc Capital Partners logo

Arc Capital Partners

Three Arch Partners - Classification

Also Known As
  • Three Arch Partners, L.P.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified